{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:12:36Z","timestamp":1783120356524,"version":"3.54.6"},"reference-count":39,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2024.1725","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T06:56:27Z","timestamp":1705474587000},"source":"Crossref","is-referenced-by-count":6,"title":["Assessment of the effects of amphiphilic poly (N\u2011vinylpyrrolidone) nanoparticles loaded with bortezomib on glioblastoma cell lines and zebrafish embryos"],"prefix":"10.3892","volume":"20","author":[{"given":"Anne","family":"Yagolovich","sequence":"first","affiliation":[{"name":"Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Kuskov","sequence":"additional","affiliation":[{"name":"D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Kulikov","sequence":"additional","affiliation":[{"name":"D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Bagrov","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Petrova","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Kukovyakina","sequence":"additional","affiliation":[{"name":"D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Isakova","sequence":"additional","affiliation":[{"name":"D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Khan","sequence":"additional","affiliation":[{"name":"N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, 115478 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Pokrovsky","sequence":"additional","affiliation":[{"name":"N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, 115478 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nosyrev","sequence":"additional","affiliation":[{"name":"Center of Bioanalytical Research and Molecular Design, Sechenov First Moscow State Medical University, 119991 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polyxeni","family":"Stamati","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Markvicheva","sequence":"additional","affiliation":[{"name":"Shemyakin\u2011Ovchinnikov Institute of Bioorganic Chemistry of The Russian Academy of Sciences, 117997 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Gasparian","sequence":"additional","affiliation":[{"name":"D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristidis","family":"Tsatsakis","sequence":"additional","affiliation":[{"name":"Center of Bioanalytical Research and Molecular Design, Sechenov First Moscow State Medical University, 119991 Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,1,17]]},"reference":[{"key":"key20240215114139_b1-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/00001813-200506000-00002","article-title":"Proteasome: An emerging target for cancer therapy","volume":"16","author":"Zavrski","year":"2005","journal-title":"Anticancer Drugs"},{"key":"key20240215114139_b2-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1081\/cnv-120030218","article-title":"Development of the proteasome inhibitor Velcade (Bortezomib)","volume":"22","author":"Adams","year":"2004","journal-title":"Cancer Invest"},{"key":"key20240215114139_b3-BR-20-3-01725","first-page":"135","article-title":"Velcade (Bortezomib) receives 2 new FDA indications: For retreatment of patients with multiple myeloma and for first-line treatment of patients with mantle-cell lymphoma","volume":"8","author":"Raedler","year":"2015","journal-title":"Am Health Drug Benefits"},{"key":"key20240215114139_b4-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/14740338.2018.1513487","article-title":"The safety of bortezomib for the treatment of multiple myeloma","volume":"17","author":"Cengiz Seval","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"888","key":"key20240215114139_b5-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020888","article-title":"Pathological mechanisms of bortezomib-induced peripheral neuropathy","volume":"22","author":"Yamamoto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20240215114139_b6-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40262-018-0679-9","article-title":"Clinical pharmacokinetics and pharmacodynamics of bortezomib","volume":"58","author":"Tan","year":"2019","journal-title":"Clin Pharmacokinet"},{"issue":"51","key":"key20240215114139_b7-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010051","article-title":"Progress on the application of bortezomib and bortezomib-based nanoformulations","volume":"12","author":"Liu","year":"2021","journal-title":"Biomolecules"},{"key":"key20240215114139_b8-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018021124","article-title":"Polymer-based drug delivery systems for cancer","volume":"35","author":"Wen","year":"2018","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"654","key":"key20240215114139_b9-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050654","article-title":"Activity of povidone in recent biomedical applications with emphasis on micro- and nano drug delivery systems","volume":"13","author":"Waleka","year":"2021","journal-title":"Pharmaceutics"},{"issue":"925","key":"key20240215114139_b10-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14050925","article-title":"Amphiphilic poly-N-vinylpyrrolidone nanoparticles as carriers for nonsteroidal, anti-inflammatory drugs: Pharmacokinetic, anti-inflammatory, and ulcerogenic activity study","volume":"14","author":"Kuskov","year":"2022","journal-title":"Pharmaceutics"},{"issue":"12446","key":"key20240215114139_b11-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012446","article-title":"In vitro assessment of poly-N-Vinylpyrrolidone\/acrylic acid nanoparticles biocompatibility in a microvascular endothelium model","volume":"23","author":"Berdiaki","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20240215114139_b12-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1023\/b:biry.0000033735.34356.21","article-title":"Interaction of polymer aggregates based on stearoyl-poly-N-vinylpyrrolidone with blood components","volume":"69","author":"Villemson","year":"2004","journal-title":"Biochemistry (Mosc)"},{"key":"key20240215114139_b13-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1021\/acs.molpharmaceut.0c00667","article-title":"Assessment of amphiphilic poly-N-vinylpyrrolidone nanoparticles' biocompatibility with endothelial cells in vitro and delivery of an anti-inflammatory drug","volume":"17","author":"Berdiaki","year":"2020","journal-title":"Mol Pharm"},{"issue":"1413","key":"key20240215114139_b14-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091413","article-title":"Amphiphilic poly(N-vinylpyrrolidone) nanoparticles conjugated with dr5-specific antitumor cytokine dr5-b for targeted delivery to cancer cells","volume":"13","author":"Yagolovich","year":"2021","journal-title":"Pharmaceutics"},{"key":"key20240215114139_b15-BR-20-3-01725","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1021\/ma971721u","article-title":"Release kinetics studies of aromatic molecules into water from block polymer micelles","volume":"31","author":"Teng","year":"1998","journal-title":"Macromolecules"},{"key":"key20240215114139_b16-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijpharm.2016.04.005","article-title":"Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro","volume":"506","author":"Akasov","year":"2016","journal-title":"Int J Pharm"},{"key":"key20240215114139_b17-BR-20-3-01725","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1134\/S199542121703008X","article-title":"Amphiphilic poly-n-vinyl-2-pyrrolidone: Synthesis, properties, nanoparticles","volume":"10","author":"Kulikov","year":"2017","journal-title":"Polym Sci Ser D"},{"key":"key20240215114139_b18-BR-20-3-01725","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1134\/S1070427216090123","article-title":"Preparation of polymer nanoparticles by self-assembling of amphiphilic poly-N-vinylpyrrolidone derivatives in aqueous media","volume":"89","author":"Kuskov","year":"2016","journal-title":"Russ J Appl Chem"},{"key":"key20240215114139_b19-BR-20-3-01725","first-page":"66","article-title":"Therapeutic efficiency of ethionamide and prothionamide","volume":"47","author":"Kozulitsyna","year":"1969","journal-title":"Probl Tuberk"},{"key":"key20240215114139_b20-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1080\/10717544.2019.1582729","article-title":"Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer","volume":"26","author":"Radu","year":"2019","journal-title":"Drug Deliv"},{"issue":"2440","key":"key20240215114139_b21-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/ma14092440","article-title":"Current landscape in organic nanosized materials advances for improved management of colorectal cancer patients","volume":"14","author":"Ginghin\u0103","year":"2021","journal-title":"Materials (Basel)"},{"issue":"755","key":"key20240215114139_b22-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050755","article-title":"Bio- and hemo-compatible silk fibroin PEGylated nanocarriers for 5-fluorouracil chemotherapy in colorectal cancer: In vitro studies","volume":"13","author":"Hudi\u021b\u0103","year":"2021","journal-title":"Pharmaceutics"},{"issue":"221","key":"key20240215114139_b23-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/ph16020221","article-title":"Sorafenib alleviates inflammatory signaling of tumor microenvironment in precancerous lung injuries","volume":"16","author":"Cicek","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"key20240215114139_b24-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.actbio.2018.09.022","article-title":"Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma","volume":"80","author":"Gu","year":"2018","journal-title":"Acta Biomater"},{"key":"key20240215114139_b25-BR-20-3-01725","doi-asserted-by":"crossref","first-page":"15453","DOI":"10.1039\/C4RA16544F","article-title":"Construction of nanoparticles based on amphiphilic PEI-PA polymers for bortezomib and paclitaxel co-delivery","volume":"5","author":"Zhang","year":"2015","journal-title":"RSC Adv"},{"key":"key20240215114139_b26-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.biopha.2014.04.003","article-title":"Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy","volume":"68","author":"Unsoy","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"key20240215114139_b27-BR-20-3-01725","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1039\/D2QM01009G","article-title":"Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration\u2020","volume":"7","author":"De Santo","year":"2023","journal-title":"Mater Chem Front"},{"issue":"127","key":"key20240215114139_b28-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00127","article-title":"Nanoscale self-assembly for therapeutic delivery","volume":"8","author":"Yadav","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"key20240215114139_b29-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jconrel.2014.12.043","article-title":"Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy","volume":"208","author":"Shen","year":"2015","journal-title":"J Control Release"},{"issue":"119885","key":"key20240215114139_b30-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119885","article-title":"Dopamine-modified poly(\u03b5-caprolactone) micelles for pH controlled delivery of bortezomib","volume":"590","author":"Liu","year":"2020","journal-title":"Int J Pharm"},{"key":"key20240215114139_b31-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"19355","DOI":"10.1021\/acsami.8b01954","article-title":"Dual pH-responsive shell-cleavable polycarbonate micellar nanoparticles for in vivo anticancer drug delivery","volume":"10","author":"Liu","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"key20240215114139_b32-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.actbio.2010.01.035","article-title":"Complement activation on degraded polyethylene glycol-covered surface","volume":"6","author":"Toda","year":"2010","journal-title":"Acta Biomate"},{"key":"key20240215114139_b33-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3109\/10717544.2014.885998","article-title":"Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection","volume":"22","author":"Xu","year":"2015","journal-title":"Drug Deliv"},{"issue":"e190013","key":"key20240215114139_b34-BR-20-3-01725","article-title":"Preparation and preliminary evaluation of povidone single-chain nanoparticles as potential drug delivery nanocarriers","volume":"4","author":"Asenjo-Sanz","year":"2019","journal-title":"Med One:"},{"key":"key20240215114139_b35-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/13543784.2020.1803827","article-title":"Proteasome inhibition for the treatment of glioblastoma","volume":"29","author":"Roth","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"key20240215114139_b36-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1166\/jbn.2021.3073","article-title":"Live in-vivo neuroimaging reveals the transport of lipophilic cargo through the blood-retina barrier with modified amphiphilic poly-N-vinylpyrrolidone nanoparticles","volume":"17","author":"Tawfik","year":"2021","journal-title":"J Biomed Nanotechnol"},{"issue":"1784","key":"key20240215114139_b37-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/nano11071784","article-title":"Zebrafish models for the safety and therapeutic testing of nanoparticles with a focus on macrophages","volume":"11","author":"Pensado-L\u00f3pez","year":"2021","journal-title":"Nanomaterials (Basel)"},{"issue":"252","key":"key20240215114139_b38-BR-20-3-01725","doi-asserted-by":"publisher","DOI":"10.3390\/biology10040252","article-title":"The zebrafish xenograft models for investigating cancer and cancer therapeutics","volume":"10","author":"Gamble","year":"2021","journal-title":"Biology (Basel)"},{"key":"key20240215114139_b39-BR-20-3-01725","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.envres.2017.05.021","article-title":"Nonlinear responses to waterborne cadmium exposure in zebrafish. An in vivo study","volume":"157","author":"Renieri","year":"2017","journal-title":"Environ Res"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T09:45:53Z","timestamp":1707990353000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2024.1725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,1,17]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2024.1725","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,17]]},"article-number":"37"}}